|
Daniel Kantor, MD, FAAN
(Medical Partnership 4 MS+)
|
Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas, LLC. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica Pharmaceuticals. The institution of Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Kantor has received research support from Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities. |
|
Richard M. Dubinsky, MD, MPH, FAAN
(University of Kansas Medical Center)
|
Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. |